Global active pharmaceutical ingredient market is expected to undergo robust growth during the forecast period owing to high adoption rate of generic drugs and increasing demand for speciality medicines. The biopharmaceutical sector and development of new drugs using active pharmaceutical ingredients are some major factors propelling the growth of this market. Additionally, rising prevalence of chronic and infectious diseases is creating demand for APIs. Also, increasing cases of COVID-19 pandemic around the world is creating demand for active pharmaceutical ingredients.

Moreover, advancements in active pharmaceutical ingredient (API) manufacturing is supporting the market growth. The increasing cases of congenital heart diseases and obesity are also anticipated to drive the market growth through 2027. However, shortening the drug development time and reducing the cost of development are some key issues API manufacturers need to tackle.

Global active pharmaceutical ingredient market can be segmented based on type of synthesis, type of manufacturer, route of administration, type of drug, therapeutic application and region. Based on type of manufacturer, the market is segmented into in-house and contract. Among them, the in-house manufacturer segment is expected to dominate the market during the forecast period as innovator companies are increasingly preferring in-house manufacturing to avail economic benefit and prevent technology leakage.

Regionally, North America dominated the global active pharmaceutical ingredient market in 2021 and is further expected to continue its dominance during the forecast period. The presence of adequate manufacturing units and technological advancement in the region are acting as key growth drivers for the market.

Major companies operating in global active pharmaceutical ingredient market include Abbott Laboratories, Inc., Teva Pharmaceutical Industries Ltd., Cipla Inc., Dr. Reddy's Laboratories Ltd., Mylan N.V., Bristol-Myers Squibb Company, Boehringer Ingelheim GmbH, Aurobindo Pharma Ltd, Merck & Co., Inc., Sun Pharmaceutical Industries Ltd., Albemarle Corporation, GlaxoSmithKline Plc, Novartis AG, F. Hoffmann-La Roche AG, Pfizer Inc., Sanofi, AstraZeneca, Eli Lilly, Aspen and AbbVie Inc., among others. The market players are investing on new product launches through extensive R&D activities. They are also undergoing partnerships, merger and collaborations to increase their share in global market.

Objective of the Study:

  • To analyze and forecast the market size of global active pharmaceutical ingredient market.
  • To forecast global active pharmaceutical ingredient market based on type of synthesis, type of manufacturer, route of administration, type of drug, therapeutic application, company and regional distribution.
  • To identify drivers and challenges for global active pharmaceutical ingredient market.
  • To examine competitive developments such as expansions, new product launches, mergers & acquisitions etc. in global active pharmaceutical ingredient market.
  • To identify and analyze the profile of leading players operating in the global active pharmaceutical ingredient market.

Click here to download the sample

TechSci Research performed both primary as well as exhaustive secondary research for this study. Initially, TechSci Research sourced a list of active pharmaceutical ingredient manufacturers across the globe. Subsequently, TechSci Research conducted primary research surveys with the identified companies. While interviewing, the respondents were also enquired about their competitors. Through this technique, TechSci Research could include the companies which could not be identified due to the limitations of secondary research.

TechSci Research calculated global active pharmaceutical ingredient market size using a bottom-up approach, where data for various end user industries and its application across various product types were recorded and forecast for the future years. TechSci Research sourced these values from the industry experts and company representatives and externally validated through analyzing historical data of these product types and applications for getting an appropriate, overall market size. Various secondary sources such as company websites, news articles, press releases, company annual reports, investor presentations and financial reports were also used by TechSci Research.

Key Target Audience:

  • Active pharmaceutical ingredient manufacturers, suppliers, distributors and companies/partners
  • Government bodies such as regulating authorities and policy makers
  • Organizations, industry associations, forums and alliances related to active pharmaceutical ingredient
  • Market research and consulting firms

The study is useful in providing answers to several critical questions that are important for the industry stakeholders such as active pharmaceutical ingredient manufacturing companies, end users etc., besides allowing them in strategizing investments and capitalizing on market opportunities.

Attribute

Details

Base Year

2021

Historical Data

2017 – 2020

Estimated Year

2022

Forecast Period

2023 – 2027

Quantitative Units

Revenue in USD Million and CAGR for 2017-2021 and 2022E-2027F

Report coverage

Revenue forecast, company share, competitive landscape, growth factors, and trends

Segments covered

  • Type of Synthesis
  • Type of Manufacturer
  • Route of Administration
  • Type of Drugs
  • Therapeutic Application

Regional scope

North America; Europe; Asia Pacific; South America; Middle East & Africa

Country scope

United States, Mexico, Canada, China, India, Japan, South Korea, Australia; Singapore; Germany, France, United Kingdom, Spain, Italy; South Africa, UAE, Saudi Arabia; Brazil, Colombia;

Key companies profiled

Abbott Laboratories, Inc., Teva Pharmaceutical Industries Ltd., Cipla Inc., Dr. Reddy's Laboratories Ltd., Mylan N.V., Bristol-Myers Squibb Company, Boehringer Ingelheim GmbH, Aurobindo Pharma Ltd, Merck & Co., Inc., Sun Pharmaceutical Industries Ltd., Albemarle Corporation, GlaxoSmithKline Plc, Novartis AG, F. Hoffmann-La Roche AG, Pfizer Inc., Sanofi, AstraZeneca, Eli Lilly, Aspen and AbbVie Inc.

Customization scope

10% free report customization with purchase. Addition or alteration to country, regional & segment scope.

Pricing and purchase options

Avail customized purchase options to meet your exact research needs. Explore purchase options

Delivery Format

PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request)

Report Scope:

In this report, global active pharmaceutical ingredient market has been segmented into following categories, in addition to the industry trends which have also been detailed below:

  • Global Active Pharmaceutical Ingredient Market, By Type of Synthesis:
    • Biotech
      • Recombinant Proteins
      • Vaccines
      • Monoclonal Antibodies
    • Fermentation
    • Plant Extracts
    • Synthetic
  • Global Active Pharmaceutical Ingredient Market, By Type of Manufacturer:
    • In-house
    • Contract
  • Global Active Pharmaceutical Ingredient Market, By Route of Administration:
    • Oral
    • Injectable
    • Topical
  • Global Active Pharmaceutical Ingredient Market, By Type of Drug:
    • Innovative
    • Generic
  • Global Active Pharmaceutical Ingredient Market, By Therapeutic Application:
    • Cardiovascular Disease
    • Oncology
    • Neurological Disorders
    • Orthopedic Disorders
    • Respiratory
    • Gastrointestinal Disorders
    • Urology
    • Others
  • Global Active Pharmaceutical Ingredient Market, By Region:
    • Asia-Pacific
      • China
      • Japan
      • India 
      • South Korea
      • Australia
      • Singapore
    • Europe
      • France
      • Germany
      • United Kingdom
      • Italy
      • Spain
    • North America
      • United States
      • Mexico
      • Canada
    • South America
      • Brazil
      • Colombia
    • Middle East & Africa
      • South Africa
      • Saudi Arabia
      • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in global active pharmaceutical ingredient market.

Available Customizations:

With the given market data, TechSci Research offers customizations according to a company’s specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Profit Margin Analysis

  • Profit margin analysis in case of direct and indirect sales channel.

It is an upcoming report to be released soon. If you wish an early delivery of this report or want to confirm the date of release, please contact us at sales@techsciresearch.com

In case you don’t find what you are looking for, please get in touch with our custom research team at sales@techsciresearch.com

1.    Product Overview

2.    Research Methodology

3.    Impact of COVID-19 on Global Active Pharmaceutical Ingredient Market

4.    Executive Summary

5.    Voice of Customer

6.    Global Active Pharmaceutical Ingredient Market Outlook

6.1.  Market Size & Forecast

6.1.1.     By Value

6.2.  Market Share & Forecast

6.2.1.     By Type of Synthesis (Biotech (Recombinant Proteins, Vaccines, Monoclonal Antibodies), Fermentation, Plant Extracts, Synthetic)

6.2.2.     By Type of Manufacturer (In-house, Contract)

6.2.3.     By Route of Administration (Oral, Injectable, Topical)

6.2.4.     By Type of Drug (Innovative, Generic)

6.2.5.     By Therapeutic Application (Cardiovascular Disease, Oncology, Neurological Disorders, Orthopedic Disorders, Respiratory, Gastrointestinal Disorders, Urology, Others)

6.2.6.     By Company (2021)

6.2.7.     By Region

6.3.  Market Attractiveness Index

7.    Asia-Pacific Active Pharmaceutical Ingredient Market Outlook

7.1.  Market Size & Forecast          

7.1.1.     By Value

7.2.  Market Share & Forecast

7.2.1.     By Type of Synthesis

7.2.2.     By Type of Manufacturer

7.2.3.     By Route of Administration

7.2.4.     By Type of Drug

7.2.5.     By Therapeutic Application

7.2.6.     By Country

7.3.  Market Attractiveness Index

7.4.  Asia-Pacific: Country Analysis

7.4.1.     China Active Pharmaceutical Ingredient Market Outlook

7.4.1.1.         Market Size & Forecast

7.4.1.1.1.             By Value

7.4.1.2.         Market Share & Forecast

7.4.1.2.1.             By Type of Synthesis

7.4.1.2.2.             By Type of Manufacturer

7.4.1.2.3.             By Route of Administration

7.4.1.2.4.             By Type of Drug

7.4.1.2.5.             By Therapeutic Application

7.4.2.     India Active Pharmaceutical Ingredient Market Outlook

7.4.2.1.         Market Size & Forecast

7.4.2.1.1.             By Value

7.4.2.2.         Market Share & Forecast

7.4.2.2.1.             By Type of Synthesis

7.4.2.2.2.             By Type of Manufacturer

7.4.2.2.3.             By Route of Administration

7.4.2.2.4.             By Type of Drug

7.4.2.2.5.             By Therapeutic Application

7.4.3.     Japan Active Pharmaceutical Ingredient Market Outlook

7.4.3.1.         Market Size & Forecast

7.4.3.1.1.             By Value

7.4.3.2.         Market Share & Forecast

7.4.3.2.1.             By Type of Synthesis

7.4.3.2.2.             By Type of Manufacturer

7.4.3.2.3.             By Route of Administration

7.4.3.2.4.             By Type of Drug

7.4.3.2.5.             By Therapeutic Application

7.4.4.     South Korea Active Pharmaceutical Ingredient Market Outlook

7.4.4.1.         Market Size & Forecast

7.4.4.1.1.             By Value

7.4.4.2.         Market Share & Forecast

7.4.4.2.1.             By Type of Synthesis

7.4.4.2.2.             By Type of Manufacturer

7.4.4.2.3.             By Route of Administration

7.4.4.2.4.             By Type of Drug

7.4.4.2.5.             By Therapeutic Application

7.4.5.     Singapore Active Pharmaceutical Ingredient Market Outlook

7.4.5.1.         Market Size & Forecast

7.4.5.1.1.             By Value

7.4.5.2.         Market Share & Forecast

7.4.5.2.1.             By Type of Synthesis

7.4.5.2.2.             By Type of Manufacturer

7.4.5.2.3.             By Route of Administration

7.4.5.2.4.             By Type of Drug

7.4.5.2.5.             By Therapeutic Application

7.4.6.     Australia Active Pharmaceutical Ingredient Market Outlook

7.4.6.1.         Market Size & Forecast

7.4.6.1.1.             By Value

7.4.6.2.         Market Share & Forecast

7.4.6.2.1.             By Type of Synthesis

7.4.6.2.2.             By Type of Manufacturer

7.4.6.2.3.             By Route of Administration

7.4.6.2.4.             By Type of Drug

7.4.6.2.5.             By Therapeutic Application

8.    Europe Active Pharmaceutical Ingredient Market Outlook

8.1.  Market Size & Forecast          

8.1.1.     By Value

8.2.  Market Share & Forecast

8.2.1.     By Type of Synthesis

8.2.2.     By Type of Manufacturer

8.2.3.     By Route of Administration

8.2.4.     By Type of Drug

8.2.5.     By Therapeutic Application

8.2.6.     By Country

8.3.  Market Attractiveness Index

8.4.  Europe: Country Analysis

8.4.1.     France Active Pharmaceutical Ingredient Market Outlook

8.4.1.1.         Market Size & Forecast

8.4.1.1.1.             By Value

8.4.1.2.         Market Share & Forecast

8.4.1.2.1.             By Type of Synthesis

8.4.1.2.2.             By Type of Manufacturer

8.4.1.2.3.             By Route of Administration

8.4.1.2.4.             By Type of Drug

8.4.1.2.5.             By Therapeutic Application

8.4.2.     Germany Active Pharmaceutical Ingredient Market Outlook

8.4.2.1.         Market Size & Forecast

8.4.2.1.1.             By Value

8.4.2.2.         Market Share & Forecast

8.4.2.2.1.             By Type of Synthesis

8.4.2.2.2.             By Type of Manufacturer

8.4.2.2.3.             By Route of Administration

8.4.2.2.4.             By Type of Drug

8.4.2.2.5.             By Therapeutic Application

8.4.3.     United Kingdom Active Pharmaceutical Ingredient Market Outlook

8.4.3.1.         Market Size & Forecast

8.4.3.1.1.             By Value

8.4.3.2.         Market Share & Forecast

8.4.3.2.1.             By Type of Synthesis

8.4.3.2.2.             By Type of Manufacturer

8.4.3.2.3.             By Route of Administration

8.4.3.2.4.             By Type of Drug

8.4.3.2.5.             By Therapeutic Application

8.4.4.     Italy Active Pharmaceutical Ingredient Market Outlook

8.4.4.1.         Market Size & Forecast

8.4.4.1.1.             By Value

8.4.4.2.         Market Share & Forecast

8.4.4.2.1.             By Type of Synthesis

8.4.4.2.2.             By Type of Manufacturer

8.4.4.2.3.             By Route of Administration

8.4.4.2.4.             By Type of Drug

8.4.4.2.5.             By Therapeutic Application

8.4.5.     Spain Active Pharmaceutical Ingredient Market Outlook

8.4.5.1.         Market Size & Forecast

8.4.5.1.1.             By Value

8.4.5.2.         Market Share & Forecast

8.4.5.2.1.             By Type of Synthesis

8.4.5.2.2.             By Type of Manufacturer

8.4.5.2.3.             By Route of Administration

8.4.5.2.4.             By Type of Drug

8.4.5.2.5.             By Therapeutic Application

9.    North America Active Pharmaceutical Ingredient Market Outlook

9.1.  Market Size & Forecast          

9.1.1.     By Value

9.2.  Market Share & Forecast

9.2.1.     By Type of Synthesis

9.2.2.     By Type of Manufacturer

9.2.3.     By Route of Administration

9.2.4.     By Type of Drug

9.2.5.     By Therapeutic Application

9.2.6.     By Country

9.3.  Market Attractiveness Index

9.4.  North America: Country Analysis

9.4.1.     United States Active Pharmaceutical Ingredient Market Outlook

9.4.1.1.         Market Size & Forecast

9.4.1.1.1.             By Value

9.4.1.2.         Market Share & Forecast

9.4.1.2.1.             By Type of Synthesis

9.4.1.2.2.             By Type of Manufacturer

9.4.1.2.3.             By Route of Administration

9.4.1.2.4.             By Type of Drug

9.4.1.2.5.             By Therapeutic Application

9.4.2.     Mexico Active Pharmaceutical Ingredient Market Outlook

9.4.2.1.         Market Size & Forecast

9.4.2.1.1.             By Value

9.4.2.2.         Market Share & Forecast

9.4.2.2.1.             By Type of Synthesis

9.4.2.2.2.             By Type of Manufacturer

9.4.2.2.3.             By Route of Administration

9.4.2.2.4.             By Type of Drug

9.4.2.2.5.             By Therapeutic Application

9.4.3.     Canada Active Pharmaceutical Ingredient Market Outlook

9.4.3.1.         Market Size & Forecast

9.4.3.1.1.             By Value

9.4.3.2.         Market Share & Forecast

9.4.3.2.1.             By Type of Synthesis

9.4.3.2.2.             By Type of Manufacturer

9.4.3.2.3.             By Route of Administration

9.4.3.2.4.             By Type of Drug

9.4.3.2.5.             By Therapeutic Application

10.  South America Active Pharmaceutical Ingredient Market Outlook

10.1.              Market Size & Forecast

10.1.1.  By Value

10.2.              Market Share & Forecast

10.2.1.  By Type of Synthesis

10.2.2.  By Type of Manufacturer

10.2.3.  By Route of Administration

10.2.4.  By Type of Drug

10.2.5.  By Therapeutic Application

10.2.6.  By Country

10.3.              Market Attractiveness Index

10.4.              South America: Country Analysis

10.4.1.  Brazil Active Pharmaceutical Ingredient Market Outlook

10.4.1.1.      Market Size & Forecast

10.4.1.1.1.           By Value

10.4.1.2.      Market Share & Forecast

10.4.1.2.1.           By Type of Synthesis

10.4.1.2.2.           By Type of Manufacturer

10.4.1.2.3.           By Route of Administration

10.4.1.2.4.           By Type of Drug

10.4.1.2.5.           By Therapeutic Application

10.4.2.  Argentina Active Pharmaceutical Ingredient Market Outlook

10.4.2.1.      Market Size & Forecast

10.4.2.1.1.           By Value

10.4.2.2.      Market Share & Forecast

10.4.2.2.1.           By Type of Synthesis

10.4.2.2.2.           By Type of Manufacturer

10.4.2.2.3.           By Route of Administration

10.4.2.2.4.           By Type of Drug

10.4.2.2.5.           By Therapeutic Application

10.4.3.  Colombia Active Pharmaceutical Ingredient Market Outlook

10.4.3.1.      Market Size & Forecast

10.4.3.1.1.           By Value

10.4.3.2.      Market Share & Forecast

10.4.3.2.1.           By Type of Synthesis

10.4.3.2.2.           By Type of Manufacturer

10.4.3.2.3.           By Route of Administration

10.4.3.2.4.           By Type of Drug

10.4.3.2.5.           By Therapeutic Application

11.  Middle East and Africa Active Pharmaceutical Ingredient Market Outlook

11.1.              Market Size & Forecast

11.1.1.  By Value

11.2.              Market Share & Forecast

11.2.1.  By Type of Synthesis

11.2.2.  By Type of Manufacturer

11.2.3.  By Route of Administration

11.2.4.  By Type of Drug

11.2.5.  By Therapeutic Application

11.2.6.  By Country

11.3.              Market Attractiveness Index

11.4.              MEA: Country Analysis

11.4.1.  South Africa Active Pharmaceutical Ingredient Market Outlook

11.4.1.1.      Market Size & Forecast

11.4.1.1.1.           By Value

11.4.1.2.      Market Share & Forecast

11.4.1.2.1.           By Type of Synthesis

11.4.1.2.2.           By Type of Manufacturer

11.4.1.2.3.           By Route of Administration

11.4.1.2.4.           By Type of Drug

11.4.1.2.5.           By Therapeutic Application

11.4.2.  Saudi Arabia Active Pharmaceutical Ingredient Market Outlook

11.4.2.1.      Market Size & Forecast

11.4.2.1.1.           By Value

11.4.2.2.      Market Share & Forecast

11.4.2.2.1.           By Type of Synthesis

11.4.2.2.2.           By Type of Manufacturer

11.4.2.2.3.           By Route of Administration

11.4.2.2.4.           By Type of Drug

11.4.2.2.5.           By Therapeutic Application

11.4.3.  UAE Active Pharmaceutical Ingredient Market Outlook

11.4.3.1.      Market Size & Forecast

11.4.3.1.1.           By Value

11.4.3.2.      Market Share & Forecast

11.4.3.2.1.           By Type of Synthesis

11.4.3.2.2.           By Type of Manufacturer

11.4.3.2.3.           By Route of Administration

11.4.3.2.4.           By Type of Drug

11.4.3.2.5.           By Therapeutic Application

12.  Market Dynamics

12.1.              Drivers

12.2.              Challenges

13.  Market Trends & Developments

14.  Competitive Landscape

14.1.              Competition Outlook

14.2.              Players Profiled (Leading Companies)

14.2.1.  Abbott Laboratories, Inc.

14.2.2.  Teva Pharmaceutical Industries Ltd.

14.2.3.  Cipla Inc.

14.2.4.  Dr. Reddy's Laboratories Ltd.

14.2.5.  Mylan N.V.

14.2.6.  Bristol-Myers Squibb Company

14.2.7.  Boehringer Ingelheim GmbH

14.2.8.  Aurobindo Pharma Ltd

14.2.9.  Merck & Co., Inc.

14.2.10.                Sun Pharmaceutical Industries Ltd.

14.2.11.                Albemarle Corporation

14.2.12.                GlaxoSmithKline Plc

14.2.13.                Novartis AG

14.2.14.                F. Hoffmann-La Roche AG

14.2.15.                Pfizer

14.2.16.                Sanofi

14.2.17.                AstraZeneca

14.2.18.                Eli Lilly

14.2.19.                Aspen

14.2.20.                AbbVie Inc

15.  Strategic Recommendations

In case you don’t find what you are looking for, please get in touch with our custom research team at sales@techsciresearch.com